SRC and melanoma: Studies have shown that CCM can be inhibited in cancer cells, with ursolic acid curbing CCM in glioblastoma [90], gold nanorods and near-infrared light impeding CCM in breast cancer cell lines [91], and SU6656, an Src inhibitor, hindering invasion by melanoma cells by inhibiting CCM [92].